20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with fluoxetine in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
---|---|---|---|---|---|
640 | 13 | 233 | 10,100 | 1,663 | 3,263 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rapoport, SI; Yuan, ZX | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and fluoxetine
Article | Year |
---|---|
Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice.
Topics: Animals; Animals, Newborn; Arachidonic Acids; Behavior, Animal; Brain Chemistry; Fluoxetine; Hydroxyeicosatetraenoic Acids; Injections, Intraperitoneal; Lipoxins; Male; Mice; Selective Serotonin Reuptake Inhibitors | 2015 |